Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
International Journal of Impotence Research
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
August 2001, Volume 13, Supplement 3, Pages S29-S34
Table of contents    Previous  Abstract  Next   Article  PDF
Apomorphine to UprimaÒ: the development of a practical erectogenic drug: a personal perspective
A Morales

Department of Urology Queen's University, Kingston, Canada

Correspondence to: A Morales, Kingston General Hospital, 76 Stuart St. Kingston, Ont., Canada K7L 2V7 E-mail: moralesa@post.queensu.ca

Abstract

The development process for apomorphine SL as an effective treatment for patients with erectile dysfunction has been somewhat unusual. As often is the case, much of the impetus for the basic research originated in academia. However, somewhat unusually, the impetus for early stage clinical research also lay in the hands of the academics. This article represents a historical perspective from one of those involved throughout.

International Journal of Impotence Research (2001) 13, Suppl 3, S29-S34.

Keywords

apomorphine SL; academia; new formulation

August 2001, Volume 13, Supplement 3, Pages S29-S34
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 2001 Nature Publishing Group